Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
01/2014
01/03/2014CA2875461A1 3-o-heteroaryl-ingenol
01/02/2014US20140005391 Quinazoline based egfr inhibitors
01/02/2014US20140005182 Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators
01/02/2014US20140005180 Phenyl amino pyrimidine compounds and uses thereof
01/02/2014US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
01/01/2014EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
01/01/2014EP2679583A1 Mesoionic pesticides
01/01/2014EP2678317A1 Benzamide derivatives as p2x7 receptor antagonists
01/01/2014CN103492370A Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
01/01/2014CN103483323A Avanafil
01/01/2014CN103483277A Preparation method and application of anilinoquinazoline compound
01/01/2014CN103483276A Preparation method for vandetanib impurity
01/01/2014CN103483275A Coupling compound of NSAID anti-inflammatory pain killers and EGFR kinase inhibitor and synthetic method and application of coupling compound
01/01/2014CN103483274A Method for preparing bensulfuron methyl
01/01/2014CN103483273A 6-methyl-5-fluorine-2,4-pyrimidinediamine compound and preparation and application thereof
01/01/2014CN103483272A Resorcarenes-polysubstitution pyrimidine derivative as well as preparation method and application of derivative
01/01/2014CN103483271A Preparation method of hydrogen bond self-assembly supramolecular photopolymerizable monomers
01/01/2014CN103483270A Synthetic method of 2-(4, 6-dimethyl pyrimidine-2-base amino formyl amino sulfonyl) methyl benzoate
01/01/2014CN103483269A Preparation methods for rosuvastatin calcium and intermediates thereof
01/01/2014CN103483268A Method for preparing 4, 6-dichloro-2-methyl-5-nitro pyrimidine
01/01/2014CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor
01/01/2014CN102532038B Method for preparing 2-methyl-1-pyrimidine-5-yl-1-(4-fluoroform methoxyl phenyl) allene-1-alcohol
12/2013
12/31/2013US8618296 Arylethynyl derivatives
12/31/2013US8618291 Process for preparing 4-[(1,6-dihydro-6-OXO-2-pyrimidinyl)amino]benzonitrile
12/31/2013US8618290 HSP90 inhibitors
12/31/2013US8618289 RAF kinase modulator compounds and methods of use thereof
12/31/2013US8618288 Pyrimidine compounds as serotonin receptor modulators
12/31/2013US8618169 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
12/31/2013US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
12/31/2013US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
12/31/2013US8618111 5-alkynyl-pyrimidines
12/31/2013US8618103 Inhibitors of JAK
12/31/2013US8618097 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
12/31/2013CA2755268C Erbb inhibitors
12/31/2013CA2629814C Bisamide inhibitors of hedgehog signaling
12/31/2013CA2622642C Dipeptidyl peptidase inhibitors
12/31/2013CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
12/31/2013CA2542492C Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
12/27/2013WO2013192345A1 Complement pathway modulators and uses thereof
12/27/2013WO2013191112A1 Fused heterocyclic compound
12/27/2013WO2013191041A1 Amide compound and use thereof for pest control
12/27/2013CA2877526A1 Complement pathway modulators and uses thereof
12/27/2013CA2877089A1 Novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
12/26/2013US20130345219 Triazinone and diazinone derivatives useful as hsp90 inhibitors
12/26/2013US20130345208 Ion channel modulators and methods of use
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/25/2013EP2675794A1 Selective fak inhibitors
12/25/2013EP2675793A1 Fak inhibitors
12/25/2013EP2675792A1 Substituted aminobutyric derivatives as neprilysin inhibitors
12/25/2013EP2455371B1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
12/25/2013EP2149564B1 Substituted pyrimidine ether compounds and their use
12/25/2013CN103477463A Organic light-emitting element, organometallic complex, light-emitting device, electronic appliance and lighting device
12/25/2013CN103468245A OLED material with carrier transmittability as well as preparation method and application thereof
12/25/2013CN103467458A Preparation methods for rosuvastatin calcium and intermediates thereof
12/25/2013CN103467390A Method for preparing 2-amino-4(3H)-quinazolinones
12/25/2013CN103467389A Copper-catalyzed synthesis method of quinazoline
12/25/2013CN103467388A Method for synthesizing aryl or heteroaryl substituted quinazoline compound
12/25/2013CN103467387A Method of preparing azoxystrobin and intermediate thereof
12/25/2013CN103467386A Aryl pyrimidine ortho-position monocyano compounds and synthesis method thereof
12/25/2013CN102146076B Anilinoquinazoline derivatives and preparation method thereof
12/25/2013CN102026984B Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols
12/25/2013CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application
12/24/2013US8614320 Preparation of aminopyrimidine compounds
12/24/2013US8614319 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
12/24/2013US8614229 Substituted indole derivatives and methods of use thereof
12/24/2013US8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
12/24/2013US8614222 Methods of preventing and treating low bone mass diseases
12/24/2013US8614220 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/24/2013US8614201 Heterocyclic amides as modulators of TRPA1
12/24/2013DE112012000828T5 Lichtemittierendes Element The light-emitting element
12/24/2013CA2567821C Quinazolinone derivatives useful as vanilloid antagonists
12/24/2013CA2561059C Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
12/19/2013WO2013186706A1 Process for the preparation of bosentan
12/19/2013WO2013185309A1 Rosuvastatin calcium and method for preparing intermediate thereof
12/19/2013US20130338360 Method for the preparation of high-purity pharmaceutical intermediates
12/19/2013US20130338167 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety
12/19/2013US20130338151 Fused ring analogues of anti-fibrotic agents
12/19/2013US20130338147 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/19/2013US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication
12/19/2013US20130336918 Compounds and methods for inhibiting phosphate transport
12/18/2013EP2674420A1 Method for producing aminophenyl pyrimidinyl alcohol derivative, and synthesis intermediate thereof
12/18/2013EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation
12/18/2013EP2421832B1 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
12/18/2013EP2398779B1 New process for the preparation of nitroorotic acid
12/18/2013EP2360156B1 Method for manufacturing neuraminic acid derivatives
12/18/2013EP1782800B1 Methods for detecting JAK3 inhibitors
12/18/2013EP1439187B1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
12/18/2013CN103459573A Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones
12/18/2013CN103459375A Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
12/18/2013CN103459369A 胍化合物 Guanidine compound
12/18/2013CN103450882A Phosphor
12/18/2013CN103450097A Preparation method of high-purity crystal-form-A erlotinib hydrochloride
12/18/2013CN103450096A Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment
12/18/2013CN103450095A Mercuric sulfamonomethoxine and preparation method thereof
12/18/2013CN103450094A Method for purifying 4, 6-dichloro pyrimidine
12/18/2013CN103450077A IRE-1A inhibitors
12/18/2013CN102234266B Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure
12/17/2013US8609852 Thiazolyl mGluR5 antagonists and methods for their use
12/17/2013US8609841 Method for the preparation of erlotinib
12/17/2013US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 427